Highlights in Graft-Versus-Host Disease From the 2023 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

A Review of Selected Presentations From the Tandem Meetings • February 15-19, 2023 • Orlando, Florida Two Post Hoc Analyses of Data From the Phase […]

Highlights in Graft-vs-Host Disease From the 2022 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

A Review of Selected Presentations From the 2022 Tandem Meetings • April 23-26, 2022 • Salt Lake City, Utah Noninvasive Genomic Characterization of Patients With Nonsclerotic […]

New Treatment Options for the Management of Acute Graft-Versus-Host Disease

H&O What is the pathophysiology of graft-vs-host disease? YC Allogeneic hematopoietic transplant is a therapy used mainly for hematologic malignancies. The putative therapeutic mechanism behind […]